Increased peripheral blood expression of electron transport chain genes in bipolar depression

Abstract

Objective To identify specific genetic pathways showing altered expression in peripheral blood of depressed subjects with bipolar disorder (BPD). Methods Illumina Sentrix BeadChip (Human-6v2)microarrays containing > 48,000 transcript probes were used to measure levels of gene expression in peripheral blood from 20 depressed subjects with BPD and in 15 healthy control subjects. Quantitative real-time reverse transcription polymerase chain reaction (qRT-PCR) was used to confirm a subset of these differences. Results A total of 1,180 genes were differentially expressed between subjects with BPD and healthy controls (fold-change > 1.3, false discovery rate-corrected p < 0.05, covaried for age and sex). Of these, 559 genes were up-regulated in BPD subjects and 621 were down-regulated. Surprisingly, there was no difference between medicated (n =11) and unmedicated (n =9) subjects with BPD for any of these genes. Pathway analysis using GeneGo MetaCore software showed that the most significantly affected pathway was the mitochondrial electron transport chain (ETC). Of the 85 objects (genes or proteins) in this pathway, 22 were up-regulated and 2 down-regulated in subjects with BPD. qRT-PCR confirmed up-regulation of nuclear encoded ETC genes in complexes I, III, IV, and V and, in addition, demonstrated up-regulation of mitochondrially encoded genes in each of these complexes. Conclusion These results suggest that increased expression of multiple components of the mitochondrial ETC may be a primary deficit in bipolar depression, rather than an effect of medication.

Brain Gene Expression Pattern of Subjects with Completed Suicide and Comorbid Substance Use Disorder

“…Since mitochondrially formed oxidants activate several signaling pathways related to apoptosis [47], this GO term was associated with the differentially expressed genes identified in this comparison, as expected.…”

Lithium and valproate modulate energy metabolism in an animal model of mania induced by methamphetamine

“…Several studies have suggested that dysfunctional cellular energy metabolism has a central role in BD, mainly in the mitochondria (Beech et al, 2010;Maurer et al, 2009;Wang, 2007;Anglin et al, 2012). Abnormalities in energy metabolism were found in functional assays and in magnetic resonance spectroscopy studies (Dager et al, 2004;Deicken et al, 1995;Frey et al, 2007;Regenold et al, 2009).…”

Utilization of Never-Medicated Bipolar Disorder Patients towards Development and Validation of a Peripheral Biomarker Profile

“…Antipsychotic and mood stabilizer medication have a well known immunomodulatory effect [26–29], which likely impacts peripheral gene expression, and thus it is uncertain whether the biomarker profiles identified largely reflect the response to medications. Two recent and important papers have moved towards addressing this issue [30,31]. In a study of major depressive disorder, Spijker et al, identified a lipopolysaccharide stimulated lymphocyte signature that could discriminate 21 unmedicated major depressive disorder patients from 21 controls, that was confirmed with 71.4% specificity and 76.9% sensitivity in a replication sample of 13 patients and 14 controls [30].…”